Filter
49
Filtered Results: 49
Text search:
Cecchi,
G.
Featured
Recommendations
1
New Publications
3
Language
Document type
Studies & Reports
21
No document type
16
Guidelines
5
Manuals
2
Strategic & Response Plan
2
Training Material
1
Situation Updates
1
Infographics
1
Countries / Regions
Africa
9
Global
5
West and Central Africa
5
Sierra Leone
3
Middle East and North Africa
3
East and Southern Africa
3
Uganda
3
Guinea
2
Liberia
2
Ukraine
1
Rwanda
1
Cameroon
1
Syria
1
Burkina Faso
1
Tanzania
1
Congo, Democratic Republic of
1
Côte d’Ivoire / Ivory Coast
1
Angola
1
Chad
1
South Sudan
1
Authors & Publishers
Publication Years
Category
Humanitarian Aid
2
Policies
2
Studies & Reports
2
Non-communicable Diseases
2
COVID-19
1
Vector Control
1
Vaccine-preventable Diseases
1
Guidelines
1
Women & Child Health
1
Humanitarian Crisis
1
General Guidelines
1
Human African Trypanosomiasis
1
Toolboxes
Studies & Reports
9
TB & Other Vulnerable Populations
5
Assessment & Studies
4
General Information & Methodology
3
Protection of Vulnerable Groups
2
Clinical Aspects & Diagnostics
2
Information & Education Material (IEC)
2
Policies & Strategies
2
Studies & Reports
2
Pediatrics
1
High Risk Groups
1
Research
1
Prevention & Preparedness
1
Infection Control General
1
For Older People
1
Humanitarian Aid
1
Camps and Camp-like Settings
1
Paediatrics
1
Long-term Care Facilities
1
Health Promotion
1
Climate Change
1
Guidelines & Manuals
1
Prevention & Measures
1
Humanitarian Aid Guidelines
1
Clinical Aspects & Diagnostics
1
Statistics & Facts
1
Snakebite envenoming
1
Health Financing Toolbox
1
Prevention & Strategies
1
TB
1
Marburg Virus Situation Reports
1
Unaccompanied Refugee Minors
1
This brief considers the rationale for shielding individuals at high risk of severe disease or death from COVID-19 in low- and middleincome countries. It provides an overview of proposed approaches to shielding, discusses the categories of individuals who may be identified for shielding, and outline...
For humanitarian organisations to respond effectively to complex crises, they require access to up-to-date evidence-based guidance. The COVID-19 crisis has highlighted the importance of updating global guidance to context-specific and evolving needs in humanitarian settings. Our study aimed to under...
Lancet Planet Health 2021; 5: e654–58
Human schistosomiasis, a parasitic and often chronic illness, is one of the major neglected tropical diseases worldwide. It is estimated that 240 million people suffer from schistosomiasis, with more than 200000 fatalities recorded each year. Schistosomiasis is caused by an infection of the blood fl...
A wide spectrum of disease severity has been described for Human African Trypanosomiasis (HAT) due to
Trypanosoma brucei rhodesiense (T.b. rhodesiense), ranging from chronic disease patterns in southern countries of East Africa to an increase in virulence towards the north. However, only limited d...
In support of the London Declaration goals, PATH aims to catalyze engagement of the diagnostics industry and product development efforts. As part of this work, PATH conducted a diagnostic landscape analysis to identify gaps and evaluated current and nascent HAT diagnostics that may provide solutions...
A clear understanding of the knowledge, attitudes and practices (KAP) of a particular community is necessary in order to improve control of human African trypanosomiasis (HAT).New screening and diagnostic tools and strategies were introduced into South Sudan, as part of integrated delivery of primar...
This training module is designed to equip health workers (HWs) with
knowledge, skills, confidence and resources to help them in their role to recommend the Human Papillomavirus
(HPV) vaccine.
Un comité OMS d’experts sur la trypanosomiase humaine africaine (THA) : lutte et surveillance, s’est réuni à Genève (Suisse), du 22 au 26 avril 2013. Le Dr H. Nakatani, sous-directeur général pour le VIH/SIDA, la tuberculose, le paludisme et les maladies tropicales négligées, a ouvert la...
Human African trypanosomiasis (HAT) has been an alarming global public health issue. The disease affects mainly poor and marginalized people in low-resource settings and is caused by two subspecies of haemoflagellate parasite, Trypanosoma brucei and transmitted by tsetse flies. Progress made in HAT ...
Gambiense human African trypanosomiasis is a deadly infectious disease affecting West and Central Africa, South Sudan and Uganda, and transmitted between humans by tsetse flies. The disease has caused several major epidemics, the latest one in the 1990s. Thanks to recent innovations such as rapid di...
This analysis focused on the chronic form of HAT caused by T. b. gambiense, as it contributes to the majority of disease burden. Information from the literature review,
product development landscape, and stakeholder interviews was compiled to:
- Identify use cases and understand current diagnosti...
Human African trypanosomiasis (HAT), or sleeping sickness, is an endemic disease in 36 sub-Saharan African countries, typically occurring in underdeveloped areas, where
health systems face significant difficulties of diverse natures.
Four initiatives have estimated the value of aid for reproductive, maternal, newborn, and child health
(RMNCH): Countdown to 2015, the Institute for Health Metrics and Evaluation (IHME), the Muskoka Initiative, and
the Organisation for Economic Co-operation and Development (OECD) policy marker. We...
Little is known about the patterns of development assistance (DA) for each component of reproductive, maternal, newborn, child and adolescent health (RMNCAH) in conflict-affected countries nor about the DA allocation in relation to the burden of disease
To provide information on trends on official development assistance (ODA) disbursement patterns for
reproductive health activities in 18 conflict-affected countries
In 2015, the United Nations set important targets to reduce premature
cardiovascular disease (CVD) deaths by 33% by 2030. Africa disproportionately
bears the brunt of CVD burden and has one of the highest risks of dying
from non-communicable diseases (NCDs) worldwide. There is currently
an epide...
Non-communicable diseases (NCDs) are the second common cause of death in sub-Saharan Africa (SSA) accounting for about 35% of all deaths, after a composite of communicable, maternal, neonatal, and nutritional diseases. Despite prior perception of low NCDs mortality rates, current evidence suggests t...
This threat assessment addresses the implications of the ongoing Marburg virus disease (MVD) outbreak in
Rwanda for the European Union/European Economic Area (EU/EEA). MVD is a severe disease in humans and,
although uncommon, it has the potential to cause epidemics with significant case fatality. ...
